Interpace Diagnostics Group Incorporated (NASDAQ:IDXG) had a decrease of 1.68% in short interest. IDXG’s SI was 4.07 million shares in December as released by FINRA. Its down 1.68% from 4.14 million shares previously. With 632,600 avg volume, 6 days are for Interpace Diagnostics Group Incorporated (NASDAQ:IDXG)’s short sellers to cover IDXG’s short positions. The SI to Interpace Diagnostics Group Incorporated’s float is 68.94%. The stock decreased 1.92% or $0.02 during the last trading session, reaching $1.02. About 575,422 shares traded. Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) has declined 18.90% since December 30, 2016 and is downtrending. It has underperformed by 35.60% the S&P500.
Merit Medical Systems, Inc. (MMSI) formed multiple top with $47.09 target or 9.00% above today’s $43.20 share price. Merit Medical Systems, Inc. (MMSI) has $2.17B valuation. The stock decreased 1.48% or $0.65 during the last trading session, reaching $43.2. About 311,298 shares traded. Merit Medical Systems, Inc. (NASDAQ:MMSI) has risen 81.84% since December 30, 2016 and is uptrending. It has outperformed by 65.14% the S&P500.
Analysts await Merit Medical Systems, Inc. (NASDAQ:MMSI) to report earnings on February, 20. They expect $0.32 EPS, up 3.23% or $0.01 from last year’s $0.31 per share. MMSI’s profit will be $16.07M for 33.75 P/E if the $0.32 EPS becomes a reality. After $0.32 actual EPS reported by Merit Medical Systems, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.
Since August 3, 2017, it had 0 insider buys, and 6 sales for $1.99 million activity. ANDERSON A SCOTT sold $1.03 million worth of stock or 25,000 shares. STANGER KENT W also sold $81,101 worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) on Monday, September 11. Millner F. Ann also sold $127,389 worth of Merit Medical Systems, Inc. (NASDAQ:MMSI) on Thursday, August 3.
Investors sentiment decreased to 1.28 in 2017 Q3. Its down 0.21, from 1.49 in 2017Q2. It is negative, as 14 investors sold Merit Medical Systems, Inc. shares while 71 reduced holdings. 44 funds opened positions while 65 raised stakes. 44.33 million shares or 0.69% more from 44.02 million shares in 2017Q2 were reported. First Advsrs Ltd Partnership reported 63,660 shares. California State Teachers Retirement Sys has 77,940 shares. American Mngmt stated it has 0.73% in Merit Medical Systems, Inc. (NASDAQ:MMSI). 55,304 were accumulated by Credit Suisse Ag. Ig Investment Mgmt Limited holds 0.01% or 31,324 shares in its portfolio. Btc Mngmt holds 0.04% in Merit Medical Systems, Inc. (NASDAQ:MMSI) or 5,369 shares. 109,327 were reported by Manufacturers Life Insurance The. 8,738 are held by Jefferies. Commercial Bank Of New York Mellon accumulated 597,038 shares. State Of Alaska Department Of Revenue, a Alaska-based fund reported 9,897 shares. Regions Fincl Corp has invested 0% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Qs Invsts Llc reported 0.05% stake. Piedmont Inv Advsrs Limited Liability Corp stated it has 0.01% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI). The Louisiana-based Louisiana State Employees Retirement Sys has invested 0.04% in Merit Medical Systems, Inc. (NASDAQ:MMSI). Fisher Asset Ltd Co holds 0.01% of its portfolio in Merit Medical Systems, Inc. (NASDAQ:MMSI) for 172,758 shares.
Among 8 analysts covering Merit Medical (NASDAQ:MMSI), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Merit Medical had 17 analyst reports since October 23, 2015 according to SRatingsIntel. On Monday, July 10 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm has “Buy” rating given on Sunday, October 8 by Canaccord Genuity. Barrington Research downgraded Merit Medical Systems, Inc. (NASDAQ:MMSI) on Friday, October 23 to “Mkt Perform” rating. The company was maintained on Thursday, November 16 by Canaccord Genuity. The stock has “Buy” rating by Craig Hallum on Thursday, July 27. Canaccord Genuity maintained the shares of MMSI in report on Thursday, October 26 with “Buy” rating. The firm earned “Buy” rating on Thursday, July 27 by Canaccord Genuity. The stock has “Buy” rating by Bank of America on Thursday, July 20. The stock of Merit Medical Systems, Inc. (NASDAQ:MMSI) earned “Buy” rating by Canaccord Genuity on Tuesday, July 19. Canaccord Genuity maintained Merit Medical Systems, Inc. (NASDAQ:MMSI) rating on Monday, September 4. Canaccord Genuity has “Buy” rating and $45.0 target.
Interpace Diagnostics Group, Inc. develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. The company has market cap of $27.39 million. The firm offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its proprietary PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. It currently has negative earnings. The Company’s clients consist primarily of physicians, hospitals, and clinics.
The post Merit Medical Systems, Inc. (MMSI) At $43.20 Forms Top; Interpace Diagnostics Group (IDXG) Sellers Decreased By 1.68% Their Shorts appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2017/12/30/merit-medical-systems-inc-mmsi-at-43-20-forms-top-interpace-diagnostics-group-idxg-sellers-decreased-by-1-68-their-shorts/
No comments:
Post a Comment